Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Liberato

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|March 1, 1993
Serum erythropoietin in patients with myelofibrosis with myeloid metaplasiaG Barosi, L N Liberato, R Guarnone
European Journal of Haematology|March 1, 1991
Small-dose iron tolerance test and body iron content in normal subjectsA Costa, L N Liberato, P Palestra, et al.
Blut|June 1, 1989
Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasiaG Barosi, L N Liberato, A Costa, et al.
British Journal of Haematology|December 1, 1988
A prognostic classification of myelofibrosis with myeloid metaplasiaG Barosi, C Berzuini, L N Liberato, et al.
British Journal of Haematology|May 1, 1989
Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasiaG Barosi, A Costa, L N Liberato, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasiaG Barosi, L N Liberato, A Costa, et al.
Cancer|November 15, 1991
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progressionG Barosi, A Buratti, A Costa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|March 1, 1993
Serum erythropoietin in patients with myelofibrosis with myeloid metaplasiaG Barosi, L N Liberato, R Guarnone
European Journal of Haematology|March 1, 1991
Small-dose iron tolerance test and body iron content in normal subjectsA Costa, L N Liberato, P Palestra, et al.
Blut|June 1, 1989
Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasiaG Barosi, L N Liberato, A Costa, et al.
British Journal of Haematology|December 1, 1988
A prognostic classification of myelofibrosis with myeloid metaplasiaG Barosi, C Berzuini, L N Liberato, et al.
British Journal of Haematology|May 1, 1989
Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasiaG Barosi, A Costa, L N Liberato, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasiaG Barosi, L N Liberato, A Costa, et al.
Cancer|November 15, 1991
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progressionG Barosi, A Buratti, A Costa, et al.
Pageof 1